Companies: 10,795·Total market cap: $144.5T

Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc.

LYELNASDAQHealthcare● Active

$12.31

+$0.34(+2.84%)

Market Cap$287242611

P/E Ratio—

52W High$45

52W Low$8.46

Avg Volume92K

Open$12.20

Beta-0.09

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Lyell Immunopharma, Inc.（LYEL）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LYEL · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Lyell Immunopharma, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Lyell Immunopharma, Inc.

$12.31+2.84%$287.2M #2

$2.19-0.46%$222.9M #3

Aldeyra Therapeutics, Inc.

$1.74+6.75%$105.0M #4

Allogene Therapeutics, Inc.

$1.85-1.60%$451.2M #5

Amarin Corporation plc

$14.20+1.94%$293.7M #6

Cabaletta Bio, Inc.

$3.20-1.54%$521.8M

关于 Lyell Immunopharma, Inc.

CEOLynn Seely

IPO DateJun 17, 2021

Employees300

CountryUS

Websitelyell.com

Lyell Immunopharma, Inc. (LYEL) is a firm specializing in T cell reprogramming, dedicated to crafting T cell therapies for individuals battling solid tumors. The company's therapeutic innovation relie…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Lyell Immunopharma, Inc.（LYEL）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 17, 2021 在 NASDAQ 上市。截至最近交易日，LYEL 股价为 $12.31，市值约为 $287.2M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Lyell Immunopharma, Inc.（LYEL）股价为 $12.31，在 NASDAQ 上市，52周区间为 $8.46 – $45.00。

LYEL 最新股价LYEL quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议